Erratum: Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib

Erratum to: Transl Lung Cancer Res 2024;13:1708-17.

In the July 2024 issue of Translational Lung Cancer Research, the article “Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib” authored by Dr. Cai et al. (1) was published with some minor errors in authors’ information. In the author list and the correspondence information, the name “Wulin Ou” should be corrected to “Wuling Ou”.

The corrected author list and correspondence information are as follows:

Qian Cai^1#, Kui Hu^2#, Shuang Dong¹, Xiaoyu Li¹, Sheng Hu¹, Wenyou Deng², Wuling Ou¹

Correspondence to: Wuling Ou, MD. Thoracic Inner Department I, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Zhuodaoquan Street 116#, Wuhan 430079, China. Email: 609700817@qq.com.

The authors regret the errors.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Cai Q, Hu K, Dong S, et al. Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib. Transl Lung Cancer Res 2024;13:1708-17. [Crossref] [PubMed]